Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice

Journal of Experimental and Clinical Cancer Research

Volumn 20, Issue 3, 2001, Pages 419-428

  Yanai, Y ^a   Furuhata, T ^a   Kimura, Y ^a   Yamaguchi, K ^a   Yasoshima, T ^a   Mitaka, T ^a   Mochizuki, Y ^a   Hirata, K ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric carcinoma; Lymph node metastasis; Lymphangiogenesis; Vascular endothelial growth factor receptor 3; Vascular endothelial growth factor C

Indexed keywords

UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL GROWTH; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; STOMACH CARCINOMA; TUMOR VOLUME;

ANIMALS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MICE; MICE, INBRED BALB C; MICE, NUDE; RECOMBINANT PROTEINS; STOMACH NEOPLASMS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 0034779882     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Purposes and principles of staging
2. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
3. Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4
4. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
5. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane
6. Molecular and biological properties of the vascular endothelial growth factor family of proteins
7. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
8. Vascular endothelial growth factor, a potent and selective angiogenic agent
9. Genomic organization of human and mouse genes for vascular endothelial growth factor C
10. Proteolytic processing regulates receptor specificity and activity of VEGF-C
11. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors
12. VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane
13. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis
14. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer
15. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines
16. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development
17. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development
18. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3
19. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer
20. Establishment and characterization of a human gastric carcinoma cell line that is highly metastatic to lymph nodes
21. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice
22. Genomic structure of human mismatch repair gene, hMLH1, and its mutation analysis in patients with hereditary non-polyposis colorectal cancer (HNPCC)
23. Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes memorial award lecture